loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient pegfilgrastim, (OBO) ATC L03AA13 for the period 01.03.2025 - 28.02.2026 (plus extension option 1x12 months) - 31053

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient pegfilgrastim, (OBO) ATC L03AA13 for the period 01.03.2025 - 28.02.2026 (plus extension option 1x12 months) - 31053 has been published on Bidding Source portal dated 24 Jan 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient pegfilgrastim, (OBO) ATC L03AA13 for the period 01.03.2025 - 28.02.2026 (plus extension option 1x12 months) - 31053
Invitation for Bids
Germany
24 Jan 2025
5 Jan 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

400529- Germany – Pharmaceutical products – Drug discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V within the framework of open-house procedures Germany 398866- Germany – Pharmaceutical products – Pharmaceutical contracts with accession option Germany 400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava Germany 412645-Awarded - Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130c Paragraph 1 SGB V in conjunction with Section 130a Paragraph 8 SGB V for the active ingredient Romosozumab Germany 381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05). Germany 382655- Germany – Pharmaceutical products – 1/DLII6/PM020 - Arzneimittel - Virostatika Germany 365213-Awarded - Germany – Pharmaceutical products – Award of sterile saline syringes as of 01.07.2025 Germany 359051-Awarded - Germany – Pharmaceutical products – Minirin Parenteral 4µg Inj.lösung Germany 350661- Germany – Pharmaceutical products – 3. Biologics tender Germany 351177-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 SGB V between IKK classic and Abacus Medicine A/S for Skyrizi(R) -- <b>Contract Value: 1,00 EUR</b> Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans